The liver is DiaPharma’s wheelhouse so we encourage you to set up a meeting with us or our partners at VLVbio to discuss how their liver injury marker, CK18*, can be useful in NASH, alcohol-associated liver disease, and drug safety research.  We are always interested in learning the latest and staying in touch with researchers and clinicians in the field.  Please contact us  to connect with our DiaPharma or VLVbio team members.

*For Research Use Only.  Not for use in diagnostic procedures.

DiaPharma EASL 2023